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Objective: Conventional cardioplegic arrest coronary artery bypass grafting after ST-segment elevation myocar-
dial infarction is associated with high mortality and morbidity. The benefits of off-pump surgery have been sug-
gested. This study randomly evaluated the impact of the off-pump technique on clinical results.
Methods:Between February 2002 and October 2007, 128 patients with ST-segment elevation myocardial infarc-
tion who underwent myocardial revascularization within 48 hours from the onset of symptoms were randomly
assigned to 2 groups: on-pump group (66 patients/51.5%) and off-pump group (63 patients/48.5%). The primary
end point was the incidence of in-hospital death and outcomes (low cardiac output syndrome, prolonged mechan-
ical and pharmacologic cardiac support, prolonged mechanical ventilation support, and postoperative length of
stay in intensive care unit and hospital). The secondary end point was the evaluation of myocardial infarct size
measured by the perioperative serum release of cardiac troponin I and the improvement of contractile cardiac
function evaluated by the wall motion score index.
Results: Overall in-hospital mortality was 4.6%. In-hospital mortality was 7.7% (5 patients) in the on-pump
group and 1.6% (1 patient) in the off-pump group (P ¼ .04). Statistically significant differences were found be-
tween the 2 groups concerning the incidence of low cardiac output syndrome (P ¼ .001), time of inotrope drugs
support (P ¼ .001), time of mechanical ventilation (P ¼ .006), reoperation for bleeding (P ¼ .04), intensive care
unit stay (P ¼ .01), and in-hospital stay (P ¼ .02). Statistically significant differences also were found between
the 2 groups concerning the incidence of in-hospital death in patients who were admitted to surgery in cardiac
shock (P ¼ .0018) and patients who underwent surgery within 6 hours from the onset of symptoms (P ¼
.0026). The procedure in 1 patient (1.6%) in the off-pump group was converted to the on-pump beating heart
technique. The serum levels of cardiac troponin I were high in the on-pump group during the first 48 hours after
surgery. Myocardial function was better in the off-pump group. There were no cardiac-related late deaths, and
patients had no recurrent cardiac events.
Conclusion: Off-pump surgery reduced early mortality and morbidity in patients with ST-segment elevation
myocardial infarction in respect to the conventional procedure. Off-pump surgery showed better results than
on-pump surgery in patients who underwent surgery within 6 hours from the onset of symptoms and in patients
with cardiogenic shock.
Acquired Cardiovascular Disease Fattouch et alDespite more than 30 years of experience with coronary ar-
tery bypass grafting (CABG), controversy still exists on the
optimal timing of surgical revascularization after acute myo-
cardial infarction (AMI). Systemic fibrinolytic treatment and
primary percutaneous coronary intervention (PCI) are both
effective and represent the first-choice treatment for acute
ST-segment elevation myocardial infarction (STEMI), al-
though several randomized studies have shown that primary
PCI is superior to thrombolytic therapy in achieving early re-
perfusion and reducing mortality.1-3 In the last 2 decades,
CABG in the presence of or immediately after AMI has
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were high4-7 and it was performed primarily in patients with
mechanical complications of AMI or refractory cardiogenic
shock.
Emergency CABG in patients with STEMI is still associ-
ated with high mortality and morbidity, and the early out-
come is poor compared with the outcome in patients with
stable angina. Furthermore, it may be advisable to delay sur-
gery whenever possible. However, in patients with STEMI,
emergency surgery within the first hours is indicated.8 Cur-
rent indications for emergency CABG in patients with
STEMI are limited to those presenting with evolving myo-
cardial ischemia refractory to optimal medical therapy, pres-
ence of left main stenosis or 3-vessel disease, ongoing
ischemia despite successful or failed PCI, complicated
PCI, or cardiogenic shock accompanied by complex coro-
nary anatomy. Operative mortality for these patients using
conventional arrested-heart CABG techniques ranges from
1.6% to 32% and strongly depends on the preoperative
hemodynamic condition.4-7,9-11rgery c March 2009
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DAbbreviations and Acronyms
AMI ¼ acute myocardial infarction
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
cTnI ¼ cardiac troponin I
ICU ¼ intensive care unit
IVP ¼ interventricular posterior artery
LAD ¼ left anterior descending artery
LCOS ¼ low cardiac output syndrome
LITA ¼ left internal thoracic artery
PCI ¼ percutaneous coronary intervention
STEMI ¼ ST-segment elevation myocardial
infarction
The use of off-pump strategies for CABG is being inten-
sively debated at present. Several retrospective studies have
suggested the benefits of off-pump surgery on in-hospital
mortality and postoperative outcomes.12-16 This study ran-
domly evaluated the impact of off-pump versus on-pump
CABG on early and midterm results in patients with STEMI
who underwent urgent CABG.
PATIENTS AND METHODS
Patients, Study Design, and Protocol
Between February 2002 and October 2007, 152 patients with STEMI
who were admitted to the University of Palermo Cardiac Surgery Depart-
ment to undergo an urgent CABG were consecutively and prospectively
screened for this study. Patients were referred to the Cardiac Surgery De-
partment from 7 hemodynamic laboratories and 12 coronary intensive
care units (ICUs) in the West Sicily district, Italy (Sicilian Network for sur-
gical treatment of patients with STEMI). Fibrinolytic or PCI therapy was ap-
plied or considered as first-choice treatment in all patients at the first ICU
admission before enrollment to undergo CABG.
Indications for surgery were recurrent myocardial ischemia refractory to
medical therapy in patients with a) a significant area of myocardium at risk
whowere not candidates for fibrinolytic or primary PCI therapy; b) coronary
lesions unsuitable for primary PCI and hemodynamic instability or angina;
with primary PCI failure and persistent symptoms or hemodynamic instabil-
ity; c) life-threatening ventricular arrhythmia and left main stenosis or 3-ves-
sel disease; d) multivessel or left main disease and hemodynamic instability;
or e) cardiogenic shock after AMI.
Exclusion criteria were a) mechanical complications of myocardial
infarction; b) cardiopulmonary resuscitation required before surgery; c)
lifesaving procedures; d) onset of cardiac shock in more than 24 hours; e)
ischemic mitral valve regurgitation more than moderate; and f) concomitant
cardiac surgical procedures, such as left ventricular aneurysm and mitral
valve repair.
Twenty-four patients were excluded, and 128 patients were eligible for
enrollment in this study.
The diagnosis of AMI was based on clinical criteria, including electro-
cardiographic signs (Q waves and ST-segment elevation) and increase in
serum myocardial enzymes levels (creatine phosphokinase and cardiac tro-
ponin I [cTnI]). The criteria for preoperative insertion of an intraaortic
balloon pump were as follows: refractory left ventricular failure, hemody-
namic instability despite catecholamine administration, refractory angina
or intractable life-threatening ventricular arrhythmias, and cardiogenicThe Journal of Thoracic and Cshock defined as a systolic blood pressure of less than 80 mm Hg, as well
as clinical signs of hypoperfusion. All patients underwent surgery within
48 hours from the onset of symptoms by 2 dedicated surgical team with
a high level of experience in off-pump and on-pump CABG.
Patients were prospectively randomized into 2 groups by card alloca-
tion: on-pump group (65 patients/51%) or off-pump group (63 patients/
49%). Randomization was blended for ICU and postoperative care staff,
including nurses, anesthetists, and cardiologists. This study was also
blended for the cardiologist who performed the clinical follow-up. The
study was approved by the institutional review board of the University
of Palermo. Each patient signed an informed consent form. Preoperative
demographic and clinical characteristic of patients are illustrated in
Table 1.
Clinical Study End Points
The primary end point of the study was the incidence of in-hospital death
and outcome of postoperative major adverse events, such as the incidence of
low cardiac output syndrome (LCOS), life-threatening arrhythmias of pro-
longed mechanical and pharmacologic cardiac support, prolonged mechan-
ical ventilation support (>48 hours), and postoperative length of stay in the
ICU and in hospital.
TABLE 1. Preoperative demographics and clinical characteristics
Variables
On-pump 65
patients (%)
Off-pump 63
patients (%)
P
value
Age (mean  SD) 61  18 63  16 .68
Age>70 y 13 (21%) 15 (24%) .38
Sex (male) 50 (77%) 38 (61%) .05
Diabetes mellitus 26 (41%) 24 (39%) .42
Hypertension 44 (68%) 38 (61%) .47
Smoking 43 (66%) 32 (52%) .07
COPD 7 (11%) 6 (9.5%) .72
Left main stenosis>50% 15 (23%) 12 (19%) .52
Cardiogenic shock 11 (17%) 13 (22%) .43
Old MI 12 (19%) 24 (39%) .02
Mean LVEF% 42  12 44  10 .71
Type of AMI:
Anterior 45 (70%) 41 (65%) .36
Inferior 20 (30%) 22 (35.5%) .38
Ejection fraction<35% 10 (15%) 8 (13%) .72
Life-threatening arrhythmias 8 (12%) 6 (9.5%) .51
Timing of surgery:
<6 h 13 (20%) 13 (22%) .68
6–24 21 (32%) 30 (48%) .07
24–48 h 31 (48%) 20 (32%) .06
Preoperative IABP 18 (28%) 20 (32%) .82
Fibrinolytic therapy 14 (21.5%) 13 (22%) .91
PCI failure 11 (17%) 12 (19%) .68
Enzymatic profile
CK-MB (ng/mL) 155  26 158  22 .81
cTnI (ng/mL) 31  18 29  15 .78
Myoglobin (ng/mL) 1920  510 1875  385 .63
GOT (U/L) 115  28 102  32 .58
GPT (U/L) 64  18 66  20 .62
COPD, Chronic obstructive pulmonary disease;MI,myocardial infarction; AMI, acute
myocardial infarction; LVEF, left ventricular myocardial infarction; IABP, intraaortic
balloon pump; PCI, percutaneous coronary intervention; CK-MB, creatine kinase
myocardial band isoenzyme; cTnI, cardiac troponin I; GOT, glutamic-oxaloacetic
transaminase; GPT, glutamic-pyruvic transaminase; SD, standard deviation. Data
are presented as mean  SD, or number (%).ardiovascular Surgery c Volume 137, Number 3 651
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infarct size or the extent of irreversible myocardial cell injury, as
measured by the perioperative serum release of cTnI and the improvement
of contractile cardiac function evaluated by transesophageal echocardiog-
raphy.
Surgical Technique and Management
Standard anesthesia was induced with fentanyl (20–50 mg/kg), midazo-
lam (0.1 mg/kg), and pancuronium bromide (0.1 mg/kg), and maintained
with a continuous infusion of fentanyl (0.5–1 mg/kg/h) and propofol
(50–200 mg/kg/h).
On-pump CABG. CABGwas performed using cardiopulmonary by-
pass (CPB) performed under moderate systemic hypothermia (32C), keep-
ing a continuous flow at 2 to 2.5 mL/min/m2 and perfusion pressure between
50 and 80mmHg.Myocardial protectionwas achievedwith intermittent an-
tegrade warm-blood cardioplegia. When the hemodynamic condition was
stable, the left internal thoracic artery (LITA) was harvested and used as
in situ graft to the left anterior descending (LAD) coronary artery. Myocar-
dial revascularization was completed using saphenous vein grafts in all
patients. All distal anastomoses were performed during a single aortic
crossclamp period. The time sequence of coronary revascularization was
first the right coronary or interventricular posterior (IVP) artery, followed
by the marginal obtuse artery, and finally by the LAD artery. During aortic
crossclamp time, cardioplegia solution was infused anterogradely through
the ascending aorta and into the venous grafts. The proximal anastomoses
of the grafts were performed with tangential clamping of the ascending aorta
during the reperfusion phase.
Off-pump CABG. CABG was performed using a commercially
available mechanical stabilizer (Octopus, Medtronic Inc, Minneapolis,
Minn). An apical suction cardiac positioning device (Starfish, Medtronic
Inc) was used in revascularization of the circumflex branch. A right ventricle
anterior wall suction, next to the acute margin of the heart, was applied
during revascularization of the interventricular posterior coronary artery
to facilitate exposure and to avoid severe right ventricle dysfunction. Intra-
coronary shunts were used for all anastomoses (Clearview, Medtronic Inc).
Temporary proximal occlusion of the target vessel was performed using 5-
0 polypropylene sutures with Teflon pledgets. The first anastomosis was
routinely performed between the LITA and the LAD, but the right coronary
or IVP artery was grafted first in patients with inferior AMI who underwent
surgery within 12 hours from onset of symptoms. The second anastomosis
was performed between the saphenous vein graft and the IVP artery and
finally to the marginal obtuse artery.
After implantation of all grafts, the mean graft flow was assessed by
Doppler transit time flowmetry for each conduit using a Transonic Systems
Inc Flowmeter (Ithaca, NY). Postoperative ICU management was standard-
ized for all patients and blended for physicians and nurses. All patients un-
derwent intraoperative and postoperative hemodynamics monitoring by
a 12-lead electrocardiogram and invasive radial artery.
Myocardial Regional Wall Motion Analysis
Intraoperative transesophageal echocardiographic control was per-
formed in all patients to evaluate global and regional myocardial function.
A 2-dimensional cardiac ultrasound from Hewlett Packard (Sonos 4500,
Palo Alto, Calif) equipped with a transesophageal echocardiographic probe
was used. Myocardial kinesia was evaluated in according to the guidelines
of the American Society of Echocardiography.17
Blood Samples
Serum creatine kinase myocardial band isoenzyme and cTnI levels were
measured preoperatively, during, and after surgery, at 6 different times:
T1 ¼ preoperatively; T2 ¼ at 1 hour, T3 ¼ at 6 hours, T4 ¼ at 12 hours,
T5 ¼ at 24 hours, and T6 ¼ at 48 hours postmyocardial revascularization.652 The Journal of Thoracic and Cardiovascular SuStatistical Analyses
Numeric values were expressed as mean standard deviation. Continu-
ous variables were compared between groups using the Student unpaired
t test. The frequency ratios between groups were compared using the chi-
square test. For repeated measures of cTnI at different times, analysis of var-
iance with the multiple comparison method (Student-Newman-Keuls test)
was used. The Statistical Package for the Social Sciences software (SPSS
Inc, Chicago, Ill) was used.
RESULTS
Demographic characteristics and intraoperative and post-
operative data are summarized in Tables 1 and 2. The 2
groups did not differ in age, type of AMI, incidence of
thrombolysis or primary PCI treatment, shock, and timing
of surgery. There were statistically significant differences
between the 2 groups in gender (P ¼ .04) and incidence of
previous myocardial infarction (P ¼ .02).
Complete myocardial revascularization was performed in
all patients with success, and no differences were observed
between the groups in the mean number of grafts per patient,
number of LITA grafts used, and mean value of grafts flow.
The procedure in 1 patient (1.6%) in the off-pump group
was converted to on-pump beating heart surgery, which
was performed with success.
Early Mortality and Outcomes
The overall in-hospital mortality rate was 4.7% (6 pa-
tients) (Table 3). Five patients (7.7%) died in the on-pump
TABLE 2. Intraoperative data and postoperative outcomes
Variables
On-pump 65
patients (%)
Off-pump 63
patients (%)
P
value
Grafts/patient 2.8  0.4 2.6  0.5 .68
Use of catecholaminesa 22 (34%) 13 (21%) .02
Time of inotrope support (d) 6.8  2.4 2.1  1.4 .001
LITA graft 60 (92%) 59 (93.6%) .82
IABP support 20 (31%) 20 (32%) .86
Time of IABP use (d) 3.6  2.4 1.9  0.4 .06
Grafts flow (mL/min):
LITA to IVA 25  11 25  8 .91
SVG to MO 35  18 38  12 .64
SVG to IVP 38  12 40  9 .71
Complications
LCOS 8 (12%) 2 (3%) .001
Renal failure 4 (6%) 3 (4.8%) .43
Tracheostomy 2 (3%) 1 (1.6%) .12
MOF 2 (3%)
Reoperation for bleeding 5 (7.7%) 1 (1.6%) .04
Sepsis 1 (1.5%)
Hospital stay (d) 12.4  5.7 8.3  1.7 .02
ICU stay (d) 3.4  2.1 1.6  0.7 .01
Mechanical ventilation (h) 24  12.7 8.5  3.7 .006
LITA, Left internal thoracic artery; IABP, intraaortic balloon pump; IVA, interventric-
ular anterior artery; SVG, saphenous vein graft; MO, obtuse marginal ramus; IVP, in-
terventricular posterior artery; LCOS, low cardiac output syndrome;MOF,multiorgan
failure; ICU, intensive care unit. Data are presented as mean  SD, or number (%).
aDopamine or dobutamine>6 mg/kg/min, adrenaline>0.08 mg/kg/min.rgery c March 2009
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(P ¼ .04). Causes of in-hospital deaths in the on-pump
group were LCOS in 3 patients (4.6%) and multiorgan fail-
ure in 2 patients (3%). In the off-pump group, 1 patient
(1.6%) died of hepatic failure 6 days after surgery. This pa-
tient had a history of severe hepatic failure and arrived in the
operating room in cardiogenic shock after an anterior AMI.
She underwent CABG with LITA to LAD and a saphenous
vein graft to the IVP. The postoperative course was unevent-
ful, and the patient was discharged from the ICU on the
second postoperative day with good left ventricle function
and in stable hemodynamic condition.
Statistically significant differences were found between
the 2 groups concerning the incidence of LCOS (P ¼
.001), time of mechanical ventilation (P ¼ .006), ICU stay
(P¼ .01), and in-hospital stay (P¼ .02). Statistically signif-
icant differences also were found between the 2 groups con-
cerning the incidence of in-hospital death in patients who
were admitted to surgery in cardiac shock (P ¼ .0018) and
patients who underwent surgery within 6 hours (P ¼
.0026) from the onset of symptoms (Table 3).
Late Outcome
Patients were followed clinically at the University of
Palermo. Follow-up ended between June and December
2007. The mean length of follow-up was 36  18 months
(range, 2–68 months). No cardiac-related late deaths oc-
curred. No recurrent angina or reintervention (surgery or
PCI) was found.
Cardiac Contractile Function
Transesophageal echocardiography was used to evaluate
myocardial contractility in all patients. There was an im-
provement in the global and regional myocardial kinesia in
the off-pump versus on-pump group from the first hour after
myocardial revascularization. The values of the wall motion
score index in the 2 groups are shown in Figure 1. In the on-
pump group, the contractile myocardium function was
slightly improved after weaning from CPBwithout a statisti-
cally significant difference from the baseline despite suc-
cessful myocardial revascularization. In the off-pump
group, myocardial kinesia was improved at T4 and T5
with a statistically significant difference compared with the
TABLE 3. In-hospital death
Variables
On-pump 65
patients (%)
Off-pump 63
patients (%) P value
Total 5 (7.7%) 1 (1.6%) .04
Cardiac shock 3/11 (27%) 1/13 (7.5%) .0018
No cardiac shock 2/54 (3.7%) 0/49 (0%)
Timing<6 ha 3/13 (23%) 1/13 (7.5%) .0026
Timing 6–48 h 2/52 (3.8%) 0/49 (0%)
aFrom onset of symptoms.The Journal of Thoracic and Cbaseline (T4 vs baseline, P< .001; T5 vs baseline, P<
.001) and the on-pump group (Figure 1).
Serum cTnI Levels
Preoperative peak maximum serum cTnI levels were not
significantly different between the 2 groups. Patients with
STEMI who underwent off-pump CABG had significantly
lower peak maximum serum cTnI levels compared with
those who underwent on-pump CABG.
In all patients, mean cTnI serum levels progressively in-
creased in both groups after myocardial revascularization
compared with preoperative values, reaching a peak value
at 24 hours after reperfusion. A statistically significant dif-
ference was observed between the 2 groups at 12 hours after
myocardial revascularization and through the observation
period (Figure 2).
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FIGURE 1. Wall motion score index for patients of both groups: time 1
(preoperative), time 2 (30 minutes after the end of myocardial revasculari-
zation), time 3 (1 hour after the end of revascularization), time 4 (2 hours
after the end of revascularization), and time 5 (4 hours after the end of
revascularization). *P< .001 in off-pump group compared with baseline.
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FIGURE 2. Total serum cTnI levels in both groups at the following mea-
surement times: 1 ¼ preoperative; 2 ¼ 1 hour post-revascularization (at the
end of all proximal anastomoses); 3 ¼ 6 hours post-revascularization, 4 ¼
12 hours post-revascularization; 5 ¼ 24 hours post-revascularization; and
6 ¼ 48 hours post-revascularization.ardiovascular Surgery c Volume 137, Number 3 653
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Experience with early myocardial surgical revasculariza-
tion (within the first 6 hours) in patients with evolving AMI
began in 1971. DeWood and colleauges9 reported hospital
mortality rates of 5.2% and 3% in patients with Q-wave
and non–Q-wave AMI, respectively.
Berg and colleagues10 reported an early death rate of
5.5%. In more recent series,4-6 early mortality from emer-
gency CABG for AMI remained high and the role of
CABGwas controversial. The reasons for this poor result in-
clude the poor preoperative status of patients (eg, cardio-
genic shock) and myocardial damage after conventional
cardioplegic arrest. In 269 consecutive patients with AMI,
Sergeant and colleagues11 found that CABG had acceptable
early and long-term risk in selected patients with evolving
myocardial infarction, regardless of their hemodynamic
state.
In the past 2 decades, the enthusiasm for emergency
CABG in evolving AMI has been diminished with the ad-
vent of intravenous thrombolytic therapy and PCI; however,
the failure of these measures in several cases and the appear-
ance of post-infarction angina revived the importance of
CABG with and without CPB in the treatment of AMI.
The use of beating heart versus conventional cardioplegic
cardiac arrest for myocardial revascularization is being in-
tensively debated.
Theoretically, off-pump CABG seems to be an ideal pro-
cedure for patients with AMI because it preserves the coro-
nary flow during surgery, avoiding global myocardial
ischemia during the cardioplegic arrest period and after
ischemia-reperfusion myocardial damage. Moreover, the
superiority of the off-pump technique versus conventional
CABG in short-term cardiac outcome is well demonstrated
by several randomized controlled studies,18,19 despite the
fact that most of them excluded patients with emergency
AMI. The disadvantage of off-pump CABG is the necessity
of extreme upward retraction of the heart during revascular-
ization of the circumflex branch, which may be difficult or
not applicable in patients with AMI and acute heart failure.
Few reports are available on the postoperative outcomes
of off-pump CABG in AMI. In 57 patients who underwent
off-pump CABG within the first week of AMI, Mohr and
colleagues12 found that CABG without CPB is a relatively
low-risk procedure. In a series of 225 patients who under-
went CABG within 7 days of AMI, Locker and colleagues13
showed that the early mortality of patients who underwent
operation within the first 48 hours with CPB was signifi-
cantly higher compared with off-pump CABG (16.5% vs
4.3%, P ¼ .044), but the mortality rate in patients who un-
derwent surgery after 48 hours was similar in both groups
(5.8% vs 3.4%, P ¼ .44). They concluded that CPB can
be used safely for most patients within the first week of
AMI, but they advocated avoiding CPB for patients who654 The Journal of Thoracic and Cardiovascular Suunderwent operation within 48 hours from the onset of
symptoms because it was associated with a high operative
mortality. Locker and colleagues14 also demonstrated that
emergency off-pump CABG for AMI results in a lower mor-
tality compared with conventional CABG (5% vs 24%);
however, the long-term results of patients without CPB
were no better than those of patients with CPB, which
may have been related to the incomplete revascularization
or inferior patency rate of anastomoses performed on the
beating heart.
Rastan and colleagues15 studied 638 consecutive patients
with acute coronary syndrome who received emergency
CABG (240 patients without CPB and 398 patients with
CPB). The authors concluded that the beating heart was as-
sociated with an improved hospital outcome and that there
were comparable long-term results for high-risk patients pre-
senting with acute coronary syndrome with or without car-
diogenic shock.
In our series, the overall in-hospital mortality rate was
4.7% (6 patients). Five patients (7.7%) died in the on-
pump group and 1 patient (1.6%) died in the off-pump
group (P ¼ .04). We found that in-hospital mortality was
significantly higher in the on-pump versus the off-pump
group in patients with preoperative cardiogenic shock
(27% vs 7.5%, P ¼ .0018) and in patients who underwent
CABG within 6 hours from the onset of AMI (23% vs
7.5%, P ¼ .0026).
The optimal timing of operation after AMI remains unde-
cided. Several studies report different results.13,14,20,21
Locker and colleagues14 demonstrated that timing in itself
is not a significant predictor of early mortality in off-pump
CABG, but it is a significant predictor in patients undergoing
operation with CPB. Creswell and colleagues20 reported that
the mortality rate was 9.1% in patients undergoing surgery
within 6 hours after onset of AMI symptoms, 8.3% in pa-
tients undergoing surgery within 6 hours to 2 days, and
5.2% in patients undergoing surgery within 2 to 14 days af-
ter AMI. In a multicenter analysis, Lee and colleagues21
showed that hospital mortality decreased considerably
with the increasing time interval between CABG and
AMI: 11.8% for less than 6 hours, 9.5% for 6 hours to 1
day, and 2.8% for more than 1 day. In a recent review,
Weis and colleagues22 reported that patients undergoing
CABGwithin 2 days of hospitalization for AMI experienced
higher mortality rates than those undergoing CABG 3 or
more days after AMI, independently of clinical acuity, and
suggested that CABG may best be deferred for 3 or more
days after admission for AMI in nonurgent cases.
In our series, the incidence of early mortality in all pa-
tients undergoing operation within 6 hours from the onset
of AMI or 6 hours to 2 days was 15.5% (4/26 patients)
and 2% (2/101 patients), respectively (P< .0001). In the
on-pump group, the incidence of early death in patientsrgery c March 2009
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was 23% (3/13 patients) and 3.8% (2/52 patients), respec-
tively (P ¼ .006). In the off-pump group, the incidence of
early death in patients undergoing operation within 6 hours
or more than 6 hours was 7.5% (1/13 patients) and 0% (0/49
patients), respectively. Our results are in agreement with
Locker and colleagues14 and suggest that the timing of sur-
gery (<6 hours) is a significant predictor of early death in the
on-pump group but not in the off-pump group. However, the
poor outcome in these patients may depend on factors such
as acute left ventricular dysfunction in the early evolving
phase of AMI with hemodynamic instability, appearance
of post-reperfusion life-threatening arrhythmias, presence
of collaterals to ensure coronary runoff after acute occlusion,
and fibrinolytic and glycoprotein inhibitor administration
that can lead to severe postoperative bleeding, specifically
in patients undergoing on-pump CABG. It is fortunate that
most patients with AMI are referred to cardiac surgeons after
the first 6 hours; however, for patients undergoing emer-
gency operation within 6 hours from the onset of symptoms,
we advocate avoiding the use of CPB because it is associated
with low in-hospital mortality.
The impact of preoperative cardiogenic shock on early
outcome in patients who underwent CABG after AMI is still
controversial. Several authors4-7 have shown that patients
with AMI presenting with cardiogenic shock have poor
outcome after CABG. On the other hand, Sergeant and
colleauges11 and Rastan and colleagues15 reported that
CABG can be performed with acceptable outcome in
patients with evolving AMI, regardless of the preoperative
hemodynamic state.
In our series, the incidence of early mortality in patients
presentingwith cardiogenic shockwas 16.5% (4/24 patients)
versus 1.9% (2/103 patients) in those without shock (P<
.0001). In the on-pump group, the incidence of early death
in patients presenting with or without shock was 27% (3/
11 patients) and 3.7% (2/54 patients), respectively (P ¼
.004). In the off-pump group, the incidence of early death
in patients presenting with or without preoperative shock
was 7.5% (1/13 patients) and 0% (0/49 patients), respec-
tively. Our data suggest that preoperative cardiogenic shock
increases early mortality after CABG in patients with AMI,
specifically in those undergoing on-pump surgery.
In this series, patients who underwent off-pump CABG
required less postoperative catecholamine drug administra-
tion (P ¼ .02) and time support (P ¼ .001) than patients
who underwent on-pump CABG. The incidence of postop-
erative LCOS (P ¼ .001) and reoperation for bleeding
(P ¼ .04) was significantly higher in the on-pump group
versus the off-pump group. Moreover, patients in the
on-pump group required more mechanical ventilation time
support (P ¼ .006) and longer ICU stay (P ¼ .01) and
in-hospital stay (P ¼ .02) than patients in the off-pump
group (Table 2). Our data are in agreement with the workThe Journal of Thoracic and Cof Kerendi and colleagues,16 who reported that patients un-
dergoing off-pump surgery received fewer blood transfu-
sions (65.9% vs 84.9%) and had significantly shorter
postoperative ICU stays (1.47 vs 3.20 days, P ¼ .016) com-
pared with patients undergoing on-pump surgery.
We think that the significant improvement of myocardial
contractility (Figure 1) and reduction of postoperative serum
cTnI release (Figure 2) in the off-pump group compared with
the on-pump group may be attributable to avoiding CPB,
since as complete and effective myocardial revascularization
was performed in all patients in both groups (measured by
intraoperative grafts flow), and all baseline characteristics
of the 2 study groups were comparable, without statistically
significant difference concerning the preoperative extent of
acute myocardial ischemia (measured by preoperative serum
levels of cTnI and creatine kinase-MB), left ventricular ejec-
tion fraction percentage, wall motion score index, and preop-
erative clinical presentation was present.
Off-pump CABG is essentially associated with an acute
conversion risk, which causes death and serious complica-
tions.23-27 The conversion risks are difficult to quantify
precisely,25 and suggested predictors of conversion have in-
cluded previous CABG, congestive heart failure, AMI, low
ejection fraction, and insufficient experience of the sur-
geon.23,26 In other series,27,28 the conversion rate was low
(0.4%–2.8%). In our study, the procedure in 1 patient
(1.6%) in the off-pump group was converted to the on-
pump beating heart technique during revascularization of
the marginal ramus for severe arterial blood hypotension,
and CABG was completed with a good result.
CONCLUSIONS
Off-pump surgery is the optimal treatment strategy for pa-
tients with STEMI, who need urgent CABG. Although
CABG is still associated with a high mortality and morbidity
in patients who undergo surgery within the first 6 hours from
the onset of symptoms and in those with cardiogenic shock,
off-pump surgery shows better results than on-pump sur-
gery. This is supported by the fact that maintaining native
coronary blood flow during off-pump surgery avoids global
myocardial ischemia, such as during conventional cardiople-
gic arrest, and post-CPB myocardial cell damage caused by
ischemia-reperfusion injury, which can contribute to poor
outcome and postoperative left ventricular dysfunction.
References
1. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O’Keefe J, et al. A
comparison of immediate coronary angioplasty with thrombolytic therapy for
acute myocardial infarction. N Engl J Med. 1993;328:673-9.
2. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A
comparison of immediate coronary angioplasty with intravenous Streptokinase
in acute myocardial infarction. N Engl J Med. 1993;328:680-4.
3. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, et al. A com-
parison of primary coronary angioplasty and intravenous thrombolytic therapy for
acute myocardial infarction: a quantitative review. JAMA. 1997;278:2093-8.ardiovascular Surgery c Volume 137, Number 3 655
Acquired Cardiovascular Disease Fattouch et al
A
C
D4. Kaul TK, Fields BL, Riggins SL, Dacumos GC, Wyatt DA, Jones CR. Coronary
artery bypass grafting within 30 days of an acute myocardial infarction. Ann
Thorac Surg. 1995;59:1169-76.
5. Yamagishi I, Sakurada T, Abe T. Emergency coronary artery bypass grafting after
acute myocardial infarction. What influences early postoperative mortality? Ann
Thorac Cardiovasc Surg. 1998;4:28-33.
6. Wasvary H, Shannon F, Basset J, O’Neill W. Timing of coronary bypass grafting
after acute myocardial infarction. Am Surg. 1997;63:710-5.
7. Quigley RL, Milano CA, Smith LR, White WD, Rankin JS, Glower DD. Progno-
sis an management of anterolateral myocardial infarction in patients with left main
disease and cardiogenic shock. The left main shock syndrome. Circulation. 1993;
88(Suppl II):65-70.
8. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al.
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery. A
report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (Committee to update the 1999 Guidelines
for Coronary Artery Bypass Graft Surgery). Circulation. 2004;110:e340-437.
9. DeWoodMA, Spores J, Berg R Jr, Kendall RW, Grunwald RP, Selinger SL, et al.
Acute myocardial infarction: a decade of experience with surgical reperfusion in
701 patients. Circulation. 1983;68(Suppl II):8-16.
10. Berg R, Kendall RW, Duvoisin GE, Ganji JH, Rudy LW, Everhart FJ. Acute myo-
cardial infarction: a surgical emergency. J Thorac Cardiovasc Surg. 1975;70:432-9.
11. Sergeant P, Blackstone E,MeynsB. Early and late outcome after CABG in patients
with evolving myocardial infarction. Eur J Cardiothorac Surg. 1997;11:848-56.
12. Mohr R, Moshkovitch Y, Shapira I, Amir G, Hod H, Gurevitch J. Coronary artery
bypass without cardiopulmonary bypass for patients with acute myocardial infarc-
tion. J Thorac Cardiovasc Surg. 1999;118:50-6.
13. Locker C, Mohr R, Paz Y, Kramer A, Lev-ran O, Pevni D, et al. Myocardial re-
vascularization for acute myocardial infarction: benefits and drawbacks of avoid-
ing cardiopulmonary bypass. Ann Thorac Surg. 2003;76:771-7.
14. Locker C, Shapira I, Paz Y, Kramer A, Gurevitch J, Matsa M, et al. Emergency
myocardial revascularization for acute myocardial infarction: survival benefit of
avoiding cardiopulmonary bypass. Eur J Cardiothorac Surg. 2000;17:234-8.
15. Rastan AJ, Eckenstein JI, Hentschel B, Funkat AK, Gummert JF, Doll N, et al.
Emergency coronary artery bypass graft surgery for acute coronary syndrome.
Beating heart versus conventional cardioplegic cardiac arrest strategies. Circula-
tion. 2006;114(Suppl I):477-85.
16. Kerendi F, Puskas JD, Craver J, Cooper WA, Jones EL, Lattouf O, et al. Emer-
gency coronary artery bypass grafting can be performed safely without cardiopul-
monary bypass in selected patients. Ann Thorac Surg. 2005;79:801-6.
17. Schiller NB, Shan PM, Crawford M, De Maria A, Devereux R, Feigenbaum H,
et al. Recommendations for quantitation of the left ventricle by two-dimensional
echocardiography. American society of echocardiography committee on stan-
dards, subcommittee on quantitation of two dimensional echocardiograms.
J Am Echocardiogr. 1989;2:358-67.
18. Van DijK, Nierich AP, Jansen EW, Nathoe HM, Suyker WJ, Diephuis JC, et al.
Early outcome after off-pump versus on-pump coronary bypass surgery: results
from a randomised study. Circulation. 2001;104:1761-6.
19. Khan NE, De Souza A, Mister R, Flather M, Clague J, Davies S, et al. A random-
ized comparison of off-pump and on-pump multivessel coronary artery bypass
surgery. N Engl J Med. 2004;350:21-8.
20. Creswell LL, Moulton MJ, Cox AL, Rosenbloom M. Revascularization after
acute myocardial infarction. Ann Thorac Surg. 1995;60:19-26.
21. Lee DC, Oz MC, Weiberg AD, Lin SX, Ting W. Optimal timing of revasculari-
zation: transmural versus nontransmural acute myocardial infarction. Ann Thorac
Surg. 2001;71:1198-204.
22. Weis ES, Chang D, Joyce D, Nwakanma LU, Yuh DD. Optimal timing of coro-
nary artery bypass after acute myocardial infarction. A review of California dis-
charge data. J Thorac Cardiovasc Surg. 2008;135:503-11.
23. Edgerton JR, Dewey TM, Magee MJ, Herbert MA, Prince SL, Jones KK, et al.
Conversion in off-pump coronary artery bypass grafting: an analysis of predictors
and outcomes. Ann Thorac Surg. 2003;76:1138-43.
24. Le´gare´ JF, Buth KJ, Hirsch GM. Conversion to on pump from OPCAB is associ-
ated with increased mortality: results from a randomised controlled trial. Eur J
Cardiothorac Surg. 2005;27:296-301.
25. Reeves BC, Ascione R, Caputo M, Angelini GD. Morbidity and mortality follow-
ing acute conversion from off-pump to on-pump coronary surgery. Eur J Cardi-
othorac Surg. 2006;29:941-7.
26. Vassiliades TA Jr, Nielsen JL, Lonquist JL. Hemodynamic collapse during
off-pump coronary artery bypass grafting. Ann Thorac Surg. 2002;73:
1874-9.656 The Journal of Thoracic and Cardiovascular Su27. Hart JC, Spooner TH, Pym J, Flavin TF, Edgerton JR,MackML, et al. A review of
1,582 consecutive octopus off-pump coronary bypass patients. Ann Thorac Surg.
2000;70:1017-20.
28. Anyanwu AC, A.L. -Ruzzeh, George SJ, Patel R, Yacoub MH, Amrani M. Con-
version of off-pump coronary by-pass without increased morbidity or change in
practice. Ann Thorac Surg. 2002;73:79-802.
Discussion
Dr T. Sundt (Rochester, Minn). I congratulate the authors on do-
ing this study. A prospectively randomized study isn’t an easy thing
to do. I guess I should add that my only conflict of interest is that I
have less concern about the controversy over on-pump versus off-
pump than I have about the use of arterial grafts. I think as a group,
cardiac surgeons would have done well to put more of our energy
into understanding the role of arterial grafts.
Nonetheless, the controversy over off-pump surgery continues,
and this is an important article. The fact that the controversy con-
tinues begs the question ‘‘Why is it that after over a decade of ex-
ploring this matter, the adoption of off-pump surgery is still pretty
modest?’’ Today, only approximately 20% of coronary revascular-
izations are done off-pump despite multiple retrospective studies
that have suggested a benefit to eliminating the pump. Why is
that? Part of the answer is that most of the randomized studies per-
formed thus far have demonstrated a relatively modest advantage to
the off-pump strategy, including little neurocognitive benefit and
a modest mortality benefit if any at all. The advocates of the off-
pump approach point to reductions in blood transfusion require-
ments and ICU length of stay, but up to now, little has been shown
with regard to the outcome that most grabs our attention: mortality.
The reason for this disconnect between retrospective and prospec-
tive studies on this subject is the same as the reason that it is difficult
to show a difference in mortality rate between PCI and coronary by-
pass. As David Taggert has argued vehemently, it is the low-risk
patients who are entered into the randomized studies, and if low-
risk patients are entered into randomized studies, you are unlikely
to see a mortality benefit regardless of what you do! So I congrat-
ulate you in particular in taking the necessary step in entering the
high-risk patients. They are indeed the ones in whom we might ex-
pect to see a difference in mortality, and you have successfully
demonstrated that. This is an important step.
With those comments, I have just a couple of questions. It is
a well-written and beautifully presented article. One question is
in regard to the randomization process. Were the same surgeons do-
ing the on-pump and off-pump cases? If they were not, then it could
be that more skilled surgeons were doing the off-pump cases than
the on-pump cases, and in fact we are looking at a surrogate for sur-
gical skill.
Dr Fattouch. This work is part of our experience in the high-risk
patients with STEMI who underwent CABG at our institution. We
started this experience at the University of Palermo in 2002, and
since the beginning of our experience, in collaboration with inter-
ventional cardiologists in the West Sicily district, we aimed to treat
these patients. Encouraged by our initial results obtained with off-
pump CABG, we designed this randomized study to evaluate the
effects of off-pump versus on-pump CABG in high-risk patients
with STEMI who underwent CABG in the early phase. We started
this study because our opinion about the superiority of off-pump
CABG in patients with STEMI is supported by the fact that avoid-
ing CPB, and not only the conventional cardioplegic arrest, leads torgery c March 2009
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Dless activation on the inflammatory cascade and less deposit into the
microvasculature of monomorphonuclear cells, which have an im-
portant role in postoperative reperfusion/ischemia damage. More-
over, the postoperative improvement of myocardial function that
was observed in the patients who underwent off-pump surgery is
due to the fact that in on-pump surgery the heart is empty and in
an empty heart the left ventricular wall geometry change leads to
impedance of coronary collateral flow supplying ischemic areas
of myocardium. The patency of these collaterals is important in
these patients to limit the extension of the area of ischemic myocar-
dial damage. Moreover, it has been shown that normal interventric-
ular septum movement is better preserved after off-pump surgery,
which improves LV function. Finally, we have a team dedicated
for this type of surgery, and all cases were done by the same
team of surgeons with high expertise in coronary artery surgery
and specifically in off-pump CABG.
Dr Sundt. A second question would be about the number of
grafts per patient. They are clearly similar between both groups
but rather modest, less than 3 grafts per patient in both cases. Do
you have data about the number of diseased vessels and complete-
ness of revascularization, or is the low number of grafts a reflection
of the patients’ extremis? Do you tend to minimize the number of
grafts in these patients? Is this a low number for you?
Dr Fattouch. In our series, the mean number of grafts per pa-
tient was 2.8 in the on-pump group and 2.6 in the off-pump group;
they are clearly similar between both groups without a statistically
significant difference. So, I agree with you that less than 3 grafts per
patient could seem modest but reflects honestly what we observed.
In these high-risk patients with STEMI, sometimes with cardiac
shock, life-threatening arrhythmias, and multivessel disease, our
policy was to perform complete myocardial revascularization.
Dr Sundt. Do you know what percentage of patients with AMI
from your network wound up coming to the operating room? WeThe Journal of Thoracic and Cjust don’t see it very often. It is uncommon for us to see a patient
in the operating room with an AMI. Most of them are rescued in
the catheter laboratory.
Dr Fattouch. The overall incidence of patients with STEMI
who need early urgent or emergency CABG is approximately 3%
to 4% among all patients who have an AMI. To answer the second
part of your question, I think that we observed this high number of
patients at our institution because we have a district network for the
treatment of these patients in collaboration with cardiologists work-
ing in several coronary ICUs and catheter laboratories since 2002.
So, in our institution we operated on more than 300 patients in the
evolving phase of STEMI, and the results are acceptable.
Dr P. Kurlansky (Miami, Fla). I also congratulate you on con-
ducting an extremely difficult study. The use of cardioplegic arrest
not only provides the opportunity for operating in a silent, bloodless
field but also provides the opportunity for substrate enhancement,
which may be particularly relevant to this particular group of pa-
tients who are acutely ischemic. In your experience or in the study,
was anything done specifically to alter the mechanisms or method-
ology of cardioplegia to provide specific substrate enhancement for
this particularly ill group of patients.?
Dr Fattouch. I think that off-pump CABG is better and superior
to on-pump in these patients because by using an intracoronary
shunt, you can conserve the native blood flow and the opportunity
to supply substrate to the ischemic myocardium. However, in the
case of occluded vessel, I think that a delay for 10 minutes in the
beating heart, the time we need to put the graft and supply blood
flow, is not an additional risk factor for ischemic myocardium.
So, it is evident that in this case we must first address the occluded
guilty vessel. Finally, in patients undergoing on-pump CABG, we
use blood cardioplegia under a normothermic CPB, which is the
best option, in our opinion. Currently, we avoid the use of CPB
for all of the reasons that I have discussed with Dr Sundt.ardiovascular Surgery c Volume 137, Number 3 657
